PARNAX LAB
Back to Cashflow Statement
|
PARNAX LAB Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹15 Cr | ₹-14 Cr | ₹12 Cr | ₹0.05 Cr | ₹5.03 Cr |
What is the latest Cash Flow from Financing Activities ratio of PARNAX LAB ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹15 Cr |
Mar2023 | ₹-14 Cr |
Mar2022 | ₹12 Cr |
Mar2021 | ₹0.05 Cr |
Mar2020 | ₹5.03 Cr |
How is Cash Flow from Financing Activities of PARNAX LAB Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹15 Cr | Positive | |
Mar2023 | ₹-14 Cr | Negative | |
Mar2022 | ₹12 Cr | 23,692.16 | |
Mar2021 | ₹0.05 Cr | -98.99 | |
Mar2020 | ₹5.03 Cr | - |
Compare Cash Flow from Financing Activities of peers of PARNAX LAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PARNAX LAB | ₹124.5 Cr | 5.2% | 7.3% | 8.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
PARNAX LAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PARNAX LAB | 5.2% |
7.3% |
8.1% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses